Axel Springer SE

  • WKN: 550135
  • ISIN: DE0005501357
  • Land: Deutschland

Nachricht vom 29.05.2019 | 20:53

Axel Springer SE: Negotiations for potential strategic investment of KKR

Axel Springer SE / Key word(s): Miscellaneous
Axel Springer SE: Negotiations for potential strategic investment of KKR

29-May-2019 / 20:53 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Disclosure of an inside information according to Article 17 MAR

Axel Springer SE: Negotiations for potential strategic investment of KKR

Berlin, 29 May 2019, 8.00 p.m. CEST

Axel Springer SE announces that the Executive Board is in negotiations with private equity firm Kohlberg Kravis Roberts (KKR) as well as Dr. h.c. Friede Springer for a potential strategic investment of KKR in Axel Springer SE.

The state of negotiations provides KKR to launch a public tender offer to the other shareholders of Axel Springer SE to acquire their shares after KKR has agreed on a consortium with companies held by Dr. h.c. Friede Springer and chief executive offer Dr. Mathias Döpfner. Dr. h.c. Friede Springer, majority shareholder Axel Springer Gesellschaft für Publizistik GmbH & Co which is held by Dr. h.c. Friede Springer and Dr. Mathias Döpfner do not intend to sell their shares in Axel Springer SE in the course of the transaction.

By this exploration, the Executive Board is pursuing its growth strategy of increasing the enterprise value in the long-term. KKR as long-term orientated investor acting jointly in a consortium with Dr. h.c. Friede Springer and Dr. Mathias Döpfner will support this strategy.

In the view of the Executive Board, it is currently open whether there will be a public tender offer and an investment by KKR in Axel Springer SE or any subsequent corporate structural measures. In particular, legal, tax and financial feasibility still needs to be reviewed in detail by the parties involved.

Contact:
Daniel Fard-Yazdani
Head of Investor Relations
+49 30 2591-77425
ir@axelspringer.de


29-May-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Expedeon AG mit attraktiver Produktpipeline

Durch die konsequente Fortsetzung der „Grow, Buy & Build“-Strategie hat die im Bereich der Entwicklung und Vermarktung von DNA-Technologien, Proteomik- und Antikörper-Konjugations-Anwendungen tätige Expedeon AG das Umsatzniveau angehoben und auf operativer Ergebnisebene zugleich den Break-Even nachhaltig überschritten. Für die kommenden Perioden ist der Ausbau der Umsatzerlöse mit den bestehenden Produkten geplant. Darüber hinaus verfügt die Expedeon AG über eine attraktive Produktpipeline mit hohem Umsatzpotenzial. Unser Kursziel liegt bei 3,20 € je Aktie. Das Rating lautet KAUFEN.

News im Fokus

Wirecard AG startet Aktienrückkaufprogramm in Höhe von bis zu 200 Mio. EUR

18. Oktober 2019, 16:04

Aktuelle Research-Studie

ad pepper media International N.V.

Original-Research: ad pepper media International N.V. (von First Berlin Equity Research GmbH): Hinzufügen

18. Oktober 2019